| Current Price | $2.80 | Mkt Cap | $35.31M |
|---|---|---|---|
| Open | $2.72 | P/E Ratio | 1.10 |
| Prev. Close | $2.72 | Div. (Yield) | N/A (N/A) |
| Daily Range | $2.72 - $2.80 | Volume | 3,050 |
| 52-Wk Range | $1.35 - $3.40 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- Verenium Announces Agreement With Tate & Lyle for Use of Enzyme Technology in the Development of Novel Food Ingredients 1/30/2012 8:00:00 AM -
- First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration 1/23/2012 8:00:00 AM -
- Verenium's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11/10/2011 7:03:16 PM -
- Verenium Corporation's CEO Discusses Q2 2011 Results - Earnings Call Transcript 8/9/2011 9:26:04 PM -
- Clean fracking: Moving to replace chemicals 11/16/2011 5:27:08 AM
- Verenium Corporation's CEO Discusses Q2 2011 Results - Earnings Call Transcript 8/9/2011 9:26:04 PM
- Verenium Corporation CEO Discusses Q1 2011 Results - Earnings Call Transcript 5/12/2011 7:10:46 PM
- Verenium Corporation Management Discusses Q4 2010 Results - Earnings Call Transcript 3/1/2011 8:21:26 PM
| Subject | Recs | Author | Date |
|---|



